In-Depth Insights into the Oxycodone Drugs Market: Growth, Trends, and Opportunities for 2025-2034
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
What fueled the previous growth in the oxycodone drugs market?
In recent years, there has been a robust expansion of the oxycodone drugs market. Its growth is projected to increase from $5.62 billion in 2024 to $6.04 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.4%. This substantial growth during the historical period can be credited to an assertive marketing strategy for Oxycontin. The drug was promoted for use in treating chronic non-malignant pain as well as cancer, causing an increase in the number of Oxycontin prescriptions for non-cancer-related pain, which in turn escalated the demand for these drugs. Moreover, the market saw an influx of synthetic opiates like Oxycodone after the Second World War, thereby contributing to its growth.
What will be the oxycodone drugs market size in the future?
The market for oxycodone drugs is projected to experience robust growth in the coming years, reaching an estimated market value of $7.92 billion by 2029, with a compound annual growth rate (CAGR) of 7.0%. This projected growth within the forecast period is due partly to an escalating occurrence of chronic pain, an increase in the number of surgeries being performed, improvements in the product pipeline, progression in drug delivery systems, and a global rise in the aging population who are experiencing more instances of chronic pain. The forecast period is also expected to see emerging trends, such as a growing demand for abuse-deterrent formulations (ADFS), the introduction of innovative delivery systems, increased usage of combination therapies, and technological improvements in production methods.
Get your oxycodone drugs market report here!
https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report
What main drivers are fueling expansion in the oxycodone drugs market?
The increasing prevalence of orthopedic conditions is anticipated to stimulate the growth of the oxycodone drug market. Orthopedic ailments encompass factors affecting the musculoskeletal system such as bones, joints, tendons, and muscles, culminating in pain, mobility issues, and functional limitations. A surge of these disorders is widely attributed to factors such as aging populations, inactive lifestyles, obesity, injuries in sports, and occupational risks. Oxycodone medications are applied in the treatment of orthopedic conditions to mitigate acute and persistent pain caused by situations like fractures, joint injuries, or discomfort after surgery, offering effective relief by interacting with the pain receptors in the central nervous system. For example, the Institute for Health Metrics and Evaluation, a research institute based in the US, projected in October 2023 that the cases of musculoskeletal disorders, or orthopedic disorders, are expected to increase by 115% (with a range of 107-124%) from 2020 to 2050, touching a projected count of 1,060 million prevalent cases by 2050. Consequently, the rising prevalence of orthopedic conditions is spurring the growth of the oxycodone drug market.
What key areas define the segmentation of the global oxycodone drugs market?
The oxycodone drugs market covered in this report is segmented –
1) By Drug Type: Short Acting Oxycodone, Long Acting Oxycodone
2) By Dosage Form: Tablets, Capsules, Injections
3) By Indication: Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Post Operative Pain, Other Indications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Short Acting Oxycodone: Immediate-Release Oxycodone Tablets, Oxycodone Oral Solution
2) By Long Acting Oxycodone: Extended-Release Oxycodone Tablets, Oxycodone Controlled-Release Formulations
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15886&type=smp
Who are the dominant players expanding their reach in the oxycodone drugs market?
Major companies operating in the oxycodone drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma L.P, Endo International plc, Amneal Pharmaceuticals LLC, Mundipharma Pty Limited, Alkermes plc, Mallinckrodt Pharmaceuticals, Alvogen Group Inc., Collegium Pharmaceutical Inc., Lannett Company Inc., Acorda Therapeutics Inc., Camurus AB, Rhodes Pharmaceuticals L.P., KVK Tech Inc., Teikoku Pharma USA Inc., Manus Aktteva Biopharma LLP, Zyla Life Sciences
What emerging trends are influencing the growth of the oxycodone drugs market?
Leading corporations in the oxycodone drug industry are directing their resources towards creating state-of-the-art drugs like oxycodone immediate-release (IR) tablets. This is to decrease drug misuse through injection and intranasal means. Oxycodone immediate-release (IR) tablets, a type of opioid painkiller, are developed for faster pain management. For instance, in July 2022, Protega Pharmaceuticals LLC, an American pharmaceutical company, introduced RoxyBond (oxycodone) immediate-release (IR) tablets in the United States market. The U.S. Food and Drug Administration (FDA) has approved RoxyBond for the treatment of intense pain that requires an opioid analgesic and when other options are not sufficient. The utilization of advanced technology in the production of RoxyBond makes it challenging to alter, thereby reducing potential misuse and abuse.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15886
Which regions are emerging as leaders in the oxycodone drugs market?
North America was the largest region in the oxycodone drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Antiparasitic Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report
Congenital Diaphragmatic Hernia Drugs Global Market Report 2024
Complicated Skin And Skin Structure Infections Drugs Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
